Quantcast
Channel: Health and Medicine
Viewing all 8759 articles
Browse latest View live

Clinical Issues in Primary Care Conference

0
0
Continuing Education Company has been organizing its' Primary Care CME Conference Series for the past 24 years. The Clinical Issues in Primary Care Conference are designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. Join us this May when we hold this conference at the Wailea Beach Marriott Resort and Spa in Wailea (Maui), HI. This course is intended for Family Practice, Internal Medicine, Nurse Practitioners, Physician Assistants and other Healthcare Professionals. Discover Wailea Beach Marriott Resort and Spa, one of the most stunning Maui, Hawaii, resorts, where you will be whisked away by spectacular beauty. Capture the panorama of our oceanfront setting from our new infinity-edge pool, featuring overwater cabanas with panoramic views not found at other resorts on Maui. The group rates start at 265+ per night. For reservation please contact 877-622-1340 and reference the name of the conference. Accreditation: This conference has been reviewed and acceptable by the AAFP for 20 prescribed credits. Primary Care Network designates this live activity for a maximum of 20 AMA PRA Category 1 Credits™. National Certification Program for Nurse Practitioners accepts AAFP Prescribed credit and AMA PRA Category 1 Credits™. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Time: 8:00 am - 12:15 pm URL: Booking: https://go.evvnt.com/63868-1 Price: Physicians: USD 725.00 NP, PA, residents, and other healthcare professionals: USD 640.00 Speakers: Please see our website for faculty information.

International Conference on New Advances in Stomatology (NAS 2016)

0
0
International Conference on New Advances in Stomatology (NAS 2016) will be held from December 1 to 3, 2016 in Sanya, China. The conference is soliciting state-of-the-art research papers in the following areas of interest: Basic Research & Disciplinary Construction Biological Impacts of Dental Materials Dental Caries Endodontics Oral and Maxillofacial Oncology/Neoplasms Oral and Maxillofacial Pathology Oral and Maxillofacial Radiology Oral and Maxillofacial Surgery Oral Immunopathology and Infection Oral Medicine Orofacial Pain Orthodontics Pediatric Dentistry Periodontology/Periodontics Prosthodontics Nursing / Health Education Please register through http://www.engii.org/RegistrationSubmission/default.aspx?ConferenceID=856&utm_source=P2P&utm_campaign=papersubmission&utm_medium=LJ

International Conference on New Advances in Ophthalmology (NAO 2016)

0
0
NAO 2016 will be a valuable and important platform for inspiring international and interdisciplinary exchange at the forefront of Ophthalmology. Conference Speakers Dr. Abdulaziz M. A. Boker King Abdulaziz University, Saudi Arabia Dr. Anita Panda Pockland Hospital, Qutab Institutional Area, New Delhi, India Prof. Giancarlo Cortese U.O. of Radiology, EOSMED, Roma, Italy Dr. Hatsadee Appassakij Prince of Songkla University, Thailand Prof. Limin Chen Chinese Academy of Medical Sciences, China Dr. MASOOR KAMALESH Cardiology Division VA Medical Center, Indianapolis, Indiana University, USA Dr. Med. Bettina Hauswald Univ.-HNO-Klinik Carl Gustav Carus Dresden, Germany Dr. Mirajul H. Kazi National Institute of Cholera & Enteric Diseases (ICMR), Kolkata, India Prof. VINCENT GEENEN University of Liege GIGA Research Institute, Liege, Belgium Prof. Xiang Ma Ophthalmology Dept. First Affiliated Hospital, Dalian Medical University, China Associate Professor Yunhai Tu Wenzhou Medical University, China Prof. Zhuo-Wei Hu Chinese Academy of Medical Sciences, China Please register through http://www.engii.org/RegistrationSubmission/default.aspx?ConferenceID=855&utm_source=P2P&utm_campaign=papersubmission&utm_medium=LJ

The 7th Association of South-East Asian Pain Societies Congress

0
0
The 7th Association of South-East Asian Pain Societies Congress (ASEAPS 2017) will bring together all of the region's clinicians, scientists, nurses, pharmacologists and researchers under one roof from 16 to 19 February 2017 in exciting Yangon with the common purpose of providing a better quality of life to our patients living with long-term pain that may have no cure – without surgery and a heavy reliance on medication. Through sponsored and plenary symposia, free papers and poster sessions and pre-congress educational sessions, ASEAPS 2017 will keep all delegates on the leading edge of the rapidly developing field of pain management as our distinguished internationally renowned experts teach, share, discuss and debate all the latest developments in this important medical subspecialty, including: - Basic science and research, new treatment options and interventional procedures for chronic pain - The role of psychology, the role of opioids in non-cancer pain, the role of nurses - Headache and craniofacial pain, arthritis, musculoskeletal pain and fibromyalgia, cancer, neuropathic, back and neck pain There has never been a more exciting time to visit the extraordinary country of Myanmar – so please join us – and help us to achieve our goal of providing our patients with the opportunity to lead full, pain-free lives. Time: 9:00 am - 6:00 pm Price: Please refer to the website: USD 0

25th Annual Primary Care Summer Conference I & II

0
0
Continuing Education Company has been organizing its' Primary Care CME Conference Series for the past 24 years. The 25th Annual Primary Care Summer Conference I & II are designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. Join us this June or July when we hold this conference at the Kiawah Island Golf Resort in Kiawah, SC. Choice of 2 weeks June 26-30 or July 3-7, 2017. This course is intended for Family Practice, Internal Medicine, Nurse Practitioners, Physician Assistants and other Healthcare Professionals. Located just 30 minutes south of historic Charleston, Kiawah Island is a sun-washed barrier island that offers both sophistication and simplicity. On Kiawah, you can dine in a five-star luxury restaurant or enjoy a simple picnic on the beach. From ten miles of romantic, unspoiled beach to 30 miles of paved, biking trails. From kayaking and canoeing adventures to alligator and birding walks. From oceanfront fine dining to riverside oyster roasts. From luxurious hotel accommodations to beautiful villas, there is no beach resort quite like Kiawah Island Golf Resort. For reservations please call 800-576-1570 and refer to Primary Care 2017 or for Session 1: #13817 and Session II: #13818. Our group rate starts at $235+ per night. Accreditation: This conference has been reviewed and acceptable by the AAFP for 20 prescribed credits. Primary Care Network designates this live activity for a maximum of 20 AMA PRA Category 1 Credits™. National Certification Program for Nurse Practitioners accepts AAFP Prescribed credit and AMA PRA Category 1 Credits™. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Booking: https://go.evvnt.com/64006-1 Prices: Physicians: USD 695.00 NP, PA, residents, and other healthcare professionals: USD 610.00 Speakers: Please see our website for faculty information. Time: 8:00 am - 12:15 pm

Understanding the impact of quality, safety, value and complexity of Telemedicine/TeleHealth ...

0
0
Overview: Executing strategies to achieve clinical, financial, technical and performance goals are leadership challenges in today’s dynamic healthcare setting. Highly performing organizations will utilize innovative health information technology training (HIT) to significantly reduce medical errors, complications, reduced readmissions and improve financial outcomes. Integration of the Electronic Health Record system (EHR) in combination with Telemedicine solutions/TeleHealth services leverages critical resources to enhance patient quality and safety. Rapid communication of vital patient information combined with sophisticated human interface technology has change the landscape of healthcare. Considerations with integration and ongoing optimization need to be realized by all levels of operations. Leaders may not be aware of the complexity of infrastructure requirements and mobile technology acquisition in order to rapidly expedite clinical outcomes. Additionally, knowledge in outcomes measurement, staff development and strategic approach to demonstrating return-on- investment are critical to organizations. The promise of improved patient quality and safety remain at the forefront of Telemedicine/TeleHealth integration. Leaders must be vigilant in pursuits of knowledge related to all aspects of this innovative technology integration. This webinar is designed to assist clinical leadership, and legal teams understand the utilization, value, and complexity of Telemedicine/TeleHealth technology integration with an emphasis on value. Why Should You Attend: Many times individuals are unaware of hidden considerations required to fully implement an EHR that may precipitate complications and errors. The emerging field of Informatics has revolutionized healthcare decision making and practice. The legal team must be aware of potential factors that are not readily discussed as factors impacting patient safety and quality. This unique webinar content includes people, process and technology areas that impact implementation and ongoing maintenance of the EHR. Areas Covered in this Webinar: Purpose, types, and utilization of Telemedicine/TeleHealth technology Transformational awareness of virtual or remote environments in care delivery People and Process considerations related to integration strategies Demonstrating value and return – on -investment Driving forces and barriers to change Impact of Informatics and Telemedicine/TeleHealth Learning Objectives: Define utilization of Telemedicine and Telehealth technology to impact patient safety and quality Discuss clinical uses of various types of telemedicine/telehealth technology Discuss technology considerations when implementing telemedicine/telehealth initiatives Identify strategies to demonstrate value and return of investment using Telemedicine/Telehealth technology Discuss adoption strategies associated with integration of technology Identify impact of electronic documentation with Telemedicine/Telehealth technology integration Who Will Benefit: Clinical Leaders , Nursing Staff, Ancillary Support Services, Legal Teams , Consultants, For more information, please visit : https://www.complianceglobal.us/product/700332/RebeccaZapatochny-Rufo/understanding-the-impact-of-quality-safety-value-and-complexity-of-telemedicine-telehealth%20integration/1 Email: support@complianceglobal.us Toll Free: +1-844-746-4244 Tel: +1-516-900-5515 Level: Intermediate Speaker Profile: Dr. Rufo is an accomplished Healthcare leader with 31 years in diverse areas of Critical Care Nursing practice, Administration, Education, Telemedicine, and Informatics. Major accomplishments are directed at extensive experience in operational and service line leadership. She has over 16 years’ experience in direct leadership roles including operational, technology and informatics. She is recognized as a national leader in Telemedicine technology. Dr. Rufo is the first leader to develop 2 large Telemedicine units within 2 large Chicago Healthcare facilities. She also is the recipient of 2 national awards for excellence in Telemedicine. Dr. Rufo is currently the Director of Patient Care Informatics System Training at Presence Health in Chicago. Her large team of instructional designers and trainers are responsible for system wide initiatives and education associated with electronic health records in both inpatient and ambulatory staff. Dr. Rufo believes in lifelong learning and has consistently served a dual role as a faculty member at several universities. She is an active Associate Professor in traditional /online Baccalaureate and Graduate Nursing programs for the past 6 years. She possess approximately 29 years of teaching a wide variety of adult learning settings, topics, and strategies. Dr. Rufo belongs to numerous professional organizations and presents nationally on telemedicine, leadership, educational and informatics topics. She is an accomplished author of several journal publications and serves as a content reviewer for 2 profession journals. Dr. Rufo is a graduate of Rush University, Chicago (DNSc) and the University of Pittsburgh (BSN/MSN). Dr. Rufo is married and has 2 daughters (freshman in college and junior in high school). She is a dedicated dog enthusiast and has a beautiful 3 year old boxer-lab. She enjoys all fitness activities including Cardio-Kickboxing, Insanity, Pilates and Yoga.

6th Global Experts Meeting on Cardiovascular Pharmacology and Cardiac Medications

0
0
Conference Series LLC invites all the participants across the globe to attend 6th Global Experts Meeting on Cardiovascular Pharmacology and Cardiac Medications April 13-14, 2017 Dubai, UAE. The main theme of the conference is “Drugs Affecting the Rhythm of the Heart”. Cardiac pharmacology 2017 focusing on advanced technologies and provides a complete knowledge of a scientific discipline that described the future and present trends in Cardiac research field. Enthralling lectures by the leading professional in cardiac field with many new ideas. Conferenceseries LLC organizes a conference series of 3000+ Global Events inclusive of 600+ Conferences, 1200+ Upcoming and Previous Symposiums and 1200+Workshops in USA, Europe & Asia with support from 1000 more scientific societies , 15 million unique visitors per year, 36 million page views per year. Publishes 700+ Open access Journals which contains over 70000 eminent personalities, reputed scientists as editorial board members with 21 days rapid review process. To know more about the conference series visit: http://www.conferenceseries.com/ Conference Highlights • Cardiac Pharmacology • Cardiology • Cardio Vascular Diseases • Cardiovascular Pharmacotherapy • Cardiovascular Medicine • Risk Factors for Cardiovascular Diseases • Interventional Cardiology • Systematic hypertension: Mechanism and Diagnosis • Neurological Disorders and Cardiovascular Diseases • Diabetes and Cardiovascular Diseases • Renal diseases and Cardiovascular Diseases • Lipoprotein Disorders and Cardiovascular Diseases • Heart diseases in varied populations • Cardiologists and Angiologists • Emerging epidemic of cardiovascular disease in developing countries • Cardio toxicity • Cardiovascular regeneration and tissue engineering • Case Reports on Cardiology • Cardiovascular Nursing • Clinical trials in Cardiology • Cardiovascular Drugs Market Analysis

Analytical Method Validation Under Good Laboratory Practices (GLPs) - By AtoZ Compliance

0
0
Key Take Away: Learn practical tips on how to validate an analytical method under the GLP requirements, including components of a validation and the importance of communication between the development and the validation labs and accuracy of transfer documents (SOPs). Overview: Any laboratory that supports products for sale or use in the United States must follow Good Laboratory Practices training (GLP), a comprehensive system that guarantees validity of results. If you work in pharmaceuticals, chemicals and petrochemicals, and environmental analyses then you are mandated to be following GLP training. One of the major tasks in GLP is validation of an analytical method. The new pharmaceuticals are very often completely new compounds, structures never studied before by chemists. Their properties – such as solubilities and acid-base nature, are unknown. Synthetic reactions may make many similar types of molecules, including structural and optical isomers. The methodologies that mean US Food and Drug Administration compliance with GLP require a separation to be able to separate and identify all major, minor, and trace components. It is no longer just determining a purity of the main component, environmental analysis is a pre-requisite. Each minor contaminant or degradation product is also important in GLP. Why Should You Attend: This analytical method validation webinar will provide practical tips on how to validate an analytical method under the GLP requirements. It is recommended for laboratories that are under, or want to be under, Good Laboratory Practices (GLP) with FDA compliance training. If you do any work that will be reported to the US Food and Drug Administration (FDA), Environmental Protection Agency (EPA), or Occupational Safety and Health Administration (OSHA), your work must be done under GLP. All methods must be validated, the proof that they do what is claimed. Common criteria are accuracy, precision, linearity, range, and several more. Areas Covered In This Webinar: This webinar will discuss the best practices of analytical method validation, including components of a validation, how to include critical reagents comparison, selectivity experiments, assessment of stability, importance of communication between the development and the validation labs and accuracy of transfer documents (SOPs training). Participants will understand - Is validation a regulated activity? When to pull the trigger for validation? Importance of suitability testing. Learning Objectives: • Method Validation • The criteria for a method • Statistical requirements • Documentation requirements • Common issues Who Will Benefit: • Analysts • Lab Supervisors and Managers • QA Managers and Personnel • Consultants • Validation Specialists • Chemists For more information, please visit : https://www.atozcompliance.com/trainings-webinar/life-sciences/laboratory-compliance/analytical-method-validation-under-good-laboratory-practices/john-c-fetzer/300105 Email: support@atozcompliance.com Toll Free: +1- 844-414-1400 Tel: +1-516-900-5509 Level: Beginner Speakers Profile: John C. Fetzer John C. Fetzer, has had over 30 year experience in HPLC methods development. He has authored or co-authored over 50 peer-reviewed papers onl iquid chromatography, has served on the editorial advisory boards of the Journal of Chromatography, Analytical Chemistry, and Analytical and Bioanalytical Chemistry.

2ND INTERNATIONAL HEART FAILURE CONFERENCE

0
0
The Conference has been designed to provide an innovative and comprehensive overview of the latest developments in cardiovascular medicine, as well as responses to the most debatable issues primarily in the areas of the prevention, diagnosis and management of heart failure, coronary artery disease, cardiac arrhythmias, stroke, acute coronary syndromes, hypertension, diabetes and metabolic syndrome. The two days event will bring together the foremost thought leaders and experts in cardiovascular medicine from the UAE, the region and all over the world to discuss strategies for disease remediation for heart, Heart Failure, Electrocardiography, and Nuclear Cardiology. These distinguished cardiologists and scientists will present data in the form of plenary sessions, symposia, oral presentations and posters and will include superb scientific material that will be carefully selected by the Scientific Abstract Review Committee. The conference will be organized around the theme “From Prevention to Treatment". The meeting will offer a superb opportunity for physicians, medical specialists and all healthcare professionals to attend expert updates and to share and exchange best practices and experiences in cardiovascular and related diseases. Prices: Doctors: AED 1000 non-Doctors: AED 600 Speakers: Dr. Samer Ellahham, Dr. Mostafa Al Shamiri, Dr. Kornelia Kotseva, Dr. Abdul Razzak Alkaddour, Dr. Walid Bsata, Dr. David Taylor, Dr. Mohammed Khalil, Dr. Juwaira Tahir, Dr. Stuart Katz, Dr. Khalid Almuti, Dr. Adel Khalifa, Dr. Peter Seferovic, Dr. Samer Ellahham, Dr. Hadi Skouri, Dr. Nizar Atallah, Dr. Ahmad Edris, Dr. Hani Sabbour, Dr. Waleed Alhabeeb, Dr. Feras Bader, Dr. David Taylor, Dr. Stuart Katz, Dr. Murat Tuzcu, Dr. Mehmet Birhan Yilmaz, Dr. Khaled Saleh Time: 8:00 am - 5:00 pm

LUPUS 2017 and ACA: Int. Congress on SLE and Asian Congress on Autoimmunity

0
0
The 12th International Congress on SLE (LUPUS 2017) and the 7th Asian Congress on Autoimmunity (ACA 2017) will take place 26-29 March 2017 in Melbourne, Australia. Autoimmunity is of course the basis of SLE – but also of so many other diseases. Rapid progress in basic and clinical research in autoimmunity has so much to offer the world of SLE. LUPUS 2017 and ACA will showcase the very best clinical, biological, and translational advances in the field of SLE and autoimmunity. The joint congress will present an exceptional program focusing on the nexus between laboratory science and clinical translation, including multidisciplinary sessions on topics from B cells to nephritis, and offer a forum for the presentation of new data, including from young investigators who we especially encourage to be part of this congress. In addition, we hope for major collaboration with industry, as it is only by working together that clinicians, academics and industry can achieve their common goal of improving the lives of patients with SLE and autoimmune disease. Abstract Deadline: 19 October 2016 Early Registration Deadline: 19 December 2016 Join us in Melbourne, Australia's capital of biomedical research and the world's most livable city. For support opportunities, please visit http://bit.ly/support_lupus2017 Chairs: Eric F. Morand (LUPUS) Yehuda Shoenfeld (ACA) Local Committee: Matthew Cook Tim Godfrey Fiona Goldblatt Alberta Hoi Richard Kitching Fabienne Mackay Mandana Nikpour (Lead for Clinical Science) Sean O'Neill David Tarlinton Carola Vinuesa International Committee: Daniel TM Chan Anne Davidson (Lead for Basic Science) Masayoshi Harigai Yasuhiro Katsumata Aisha Lateef CS Lau Sandra Navarra Nan Shen Speakers: Matthew Brown, Ian Bruce, Daniel TM Chan, Matthew Cook, Joe Craft, Lindsey Criswell, Anne Davidson, Betty Diamond, Andrea Doria, Thomas Dörner, Keith Elkon, Richard Furie, Dafna Gladman, Tim Godfrey, Fiona Goldblatt, Tom Gordon, Doug Green, John Hanly, James Harris, Frederic Houssiau, Sarah Jones, Yoshihiro Katsumata, Munther Khamashta, Richard Kitching, Steven Krilis, Aisha Lateef, CS Lau, Andrew Lew, Zhanguo Li, Fabienne Mackay, Eoin McKinney, Eric Morand, Laurence Morel, Sandra Navarra, Mandana Nikpour, Sean Oneill, Virginia Pascual, Jamie Rossjohn, Brad Rovin, Nan Shen, Ken Smith, Ling Yun Sun, Tsutomu Takeuchi, David Tarlinton, Ranjeny Thomas, Ronald van Vollenhoven, Fabien Vincent, Carola Vinuesa, Nicholas J Wilson, David Wofsy, Jismoon Yazdany, Di Yu, Susan Yung Price: Visit the website for registration information: 0 Time: 3:00 pm - 6:00 pm

To Quality and Beyond: Recent Developments in Medicare Reimbursement - By AtoZ Compliance

0
0
Key Take Away: This webinar discusses changes in the physician payment landscape arising from several of physician quality reporting system, with particular focus on the Medicare changes resulting from the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). And, addresses the shift in Medicare away from traditional fee for service payment models, towards more value- and quality-based payment by examining the reporting requirements and new compliance difficulties that physicians and physician practices will need to understand. Overview: This webinar discusses the history of Medicare's physician quality and value initiatives and recent changes in Medicare reimbursement and Medicare insurance. Why Should You Attend: Medicare currently operates several interconnected quality reporting systems. These are: (1) the Physician Quality Reporting System (PQRS); (2) the “Meaningful Use” program; and (3) the Value-based Payment Modifier. These programs will be incorporated into Medicare’s forthcoming Merit-based Incentive Payment System (MIPS). Data reported today will determine whether physicians receive upward or downward payment adjustments to their compensation in the future. Currently, physicians face a range of upward and downward payment adjustments to the entire universe of their Medicare Physician Fee Schedule payments; under MIPS, this amount will eventually be +/- 9%. Improper reporting may require repayment of money to Medicare, and may result in exposure under the Federal False Claims Act, which recently had its penalties nearly doubled. Given the complexity of these systems, and the potential risk associated with improper reporting, physicians must develop effective compliance strategies to minimize their risks. Areas Covered In This Webinar: In recent years Medicare has increased the number of programs which track physician-reported data. These programs, which include PQRS, EHR Meaningful Use, and the Value-based Payment Modifier, each bind Medicare physician fee schedule (MPFS) patients to the reporting of data. The process of reporting such data, however, is complex. Physicians must choose which reporting mechanism is most appropriate for them, and different mechanisms require the reporting of different data. Physicians who fail to report properly may face reductions in MPFS payments. In addition, there is often a delay of up to two years between when the data is reported and when payment adjustments are applied. Moreover, improper reporting that avoids a payment reduction could result in an overpayment, which could become a false claim under the federal False Claims Act. The Merit-based Incentive Payment System (MIPS) will consolidate much of the current reporting, but will ultimately increase the range of upward or downward payment adjustments for physicians. Learning Objectives: • Examine the three physician reporting programs currently in use by Medicare: PQRS, Meaningful Use, and the Value-based Payment Modifier • Get a brief background for each program, and discuss common problems and areas of overlap between them • Know MIPS, and how the current systems relate to it • Understand the False Claims Act liability inherent in both the current systems and in MIPS, and how improper reporting under these systems can potentially result in overpayments • Learn proactive steps that physician practices can take to help ensure compliance with these systems to avoid such liability Who Will Benefit: • Physicians • Physician Practice Managers • Compliance Officers for Health Care Providers • Medical Staff • Allied Health Professionals For more information, please visit : https://www.atozcompliance.com/trainings-webinar/healthcare/audit-data-security/quality-and-beyond-recent-developments-in-medicare-reimbursement/daniel-shay/300118 Email: support@atozcompliance.com Toll Free: +1- 844-414-1400 Tel: +1-516-900-5509 Level: Intermediate Speakers Profile: Daniel Shay DANIEL F. SHAY is an attorney with Alice G. Gosfield and Associates, P.C. His practice is restricted to health law and health care regulation focusing primarily on physician representation, fraud and abuse compliance, Medicare Part B reimbursement, and HIPAA compliance in the physician context. He also has a keen interest in intellectual property issues, including copyright, trademark, data control, and confidentiality. He has also focused his attention on provider control of commerce in data, electronic health records license agreements, physician advertising, enrollment in Medicare, quality reporting and quality measurement, physician use of non-physician practitioners, and physician use of social media. He speaks publicly and has published on all of these topics both in the trade press and in major chapters in previous years of the HEALTH LAW HANDBOOK. He also regularly speaks to resident physicians on what to expect in their employment contracts. Mr. Shay received his Bac

5th Annual MEDTECH ACCESS Leaders Forum

0
0
This three day event is the “must-attend” event for all senior directors at medical device companies who are looking to enhance market access for their products. 6 EVENTS IN ONE: 1. International Medical Device Payer & HTA Forum 2. HTA-Related Evidence Development for Medical Devices 3. Medtech Procurement & Tendering Excellence 4. Market Access for Surgical & Implantable Devices 5. Market Access for Molecular Diagnostics 6. Market Access for Medical Devices in Germany

International Conference on Anesthesia and Pain Management (APM 2016)

0
0
APM 2016 will be a valuable and important platform for inspiring international and interdisciplinary exchange at the forefront of Anesthesia and Pain Management. Conference Speakers Conference Speakers Dr. Abdulaziz M. A. Boker King Abdulaziz University, Saudi Arabia Prof. Giancarlo Cortese U.O. of Radiology, EOSMED, Roma, Italy Dr. Hatsadee Appassakij Prince of Songkla University, Thailand Prof. Limin Chen Chinese Academy of Medical Sciences, China Dr. MASOOR KAMALESH Cardiology Division VA Medical Center, Indianapolis, Indiana University, USA Dr. Med. Bettina Hauswald Univ.-HNO-Klinik Carl Gustav Carus Dresden, Germany Dr. Mirajul H. Kazi National Institute of Cholera & Enteric Diseases (ICMR), Kolkata, India Prof. VINCENT GEENEN University of Liege GIGA Research Institute, Liege, Belgium Prof. Xiang Ma Ophthalmology Dept. First Affiliated Hospital, Dalian Medical University, China Associate Professor Yunhai Tu Wenzhou Medical University, China Prof. Zhuo-Wei Hu Chinese Academy of Medical Sciences, China Please register through http://www.engii.org/RegistrationSubmission/default.aspx?ConferenceID=854&utm_source=P2P&utm_campaign=papersubmission&utm_medium=LJ

The 2nd Int'l Conference on Health Policy and Management (HPM 2016)

0
0
HPM 2016 will be a valuable and important platform for inspiring international and interdisciplinary exchange at the forefront of Health Policy and Management. Conference Speakers Dr. Abdulaziz M. A. Boker King Abdulaziz University, Saudi Arabia Prof. Giancarlo Cortese U.O. of Radiology, EOSMED, Roma, Italy Dr. Hatsadee Appassakij Prince of Songkla University, Thailand Prof. Limin Chen Chinese Academy of Medical Sciences, China Dr. MASOOR KAMALESH Cardiology Division VA Medical Center, Indianapolis, Indiana University, USA Dr. Med. Bettina Hauswald Univ.-HNO-Klinik Carl Gustav Carus Dresden, Germany Dr. Mirajul H. Kazi National Institute of Cholera & Enteric Diseases (ICMR), Kolkata, India Prof. VINCENT GEENEN University of Liege GIGA Research Institute, Liege, Belgium Prof. Xiang Ma Ophthalmology Dept. First Affiliated Hospital, Dalian Medical University, China Associate Professor Yunhai Tu Wenzhou Medical University, China Prof. Zhuo-Wei Hu Chinese Academy of Medical Sciences, China Please register through http://www.engii.org/RegistrationSubmission/default.aspx?ConferenceID=853&utm_source=P2P&utm_campaign=papersubmission&utm_medium=LJ

Basic to Advanced Echocardiography: From the Blue Ridge Mountains of Asheville

0
0
Unique Features: - Faculty members are clinical sonographers and echocardiologists - Easy access to faculty members during the entire conference - Afternoon on pediatric/adult congenital echocardiography - Lab accreditation (IAC Echocardiography) - Live scanning hands-on - Presentations involving multimodality imaging URL: Brochure: https://go.evvnt.com/64066-1 Prices: Fellows in Training, Sono, RN: USD 565, MD, PhD, DO, PharmD: USD 750 Time: 7:30 am to 11:30 am

The Best Way to Develop or Improve a Master Validation Plan - By Compliance Global Inc

0
0
Overview: How to develop or improve upon a Master Validation Plan / Validation Master Plan or System that meets U.S. FDA CGMP, ICH Q-series, and ISO 13485 expectations and requirements. FDA Warning Letters and recent high-profile recalls indicate major cGMP regulations deficiencies in many companies. One major failing is lack of sufficient or targeted risk-based company-wide V&V planning. Starting with a Validation Master Plan, evaluating its elements against ISO 14971 process hazard analysis / risk management plan, allows development of meaningful product validations. The roles of different V&V protocols. How to employ equipment / process DQs, IQs, OQs, and PQs, or their equivalents per ASTM E2500, against a background of limited company resources (personnel, budget, time). A matrix simplifies “as-product”, “in-product”, process, and equipment, et al, software V&VT, assuring key FDA requirements are not overlooked. The QMS and 21 CFR Part 11 must also be considered. Why Should You Attend: Verification and validation requirements have always been part of the US FDA’s GMPs. However, with increasing technology, both industry and regulatory agencies expectations have increased. Recent high-profile field problems indicate that V&V activities are not planned or carried out as completely as expected, cannot be analyzed as to inventory impact, do not consider allowable “worst case” inputs, are not documented in a top tier Master Validation Plan, and may not be fully utilizing the power of current risk management tools, as identified in ISO 14971. The FDA / ICH Q-series provide valuable insights for all regulated industries, not just pharma. The billions of dollars spent by industry annually for V&V are not providing the product safety or efficacy seemingly promised. For most companies, the fixes are not rocket-science, but proper up-front V&V planning and execution, documented in a corporate MVP and implemented by other V&V documents. Areas Covered in this Webinar: The Master Validation Plan and its structure Product Validation – how it differs from process / equipment V&V Process / Equipment / Facility Validation -- including FDA's recent Guidance When and How to use DQ, IQ, OQ, PQ, or their equivalents How to use Product Risk Management Tools (per ISO 14971 and ICH Q9) The 11 key documents for software validation Incorporating 21 CFR Part 11 requirements Suggested “test case” formats Putting it all together Learning Objectives: Sort through all the differing theories, outright misstatements on Internet forums and understand a field-proven system. Understand the unstated regulatory requirements for a MVP/ VMP. The nature and structure of the VMP document(s). How the VMP feeds the individual Validation Plan. Know the similarities and differences in: Product V&V Process V&V Equipment V&V Software / Firmware V&V – In-product, As-product, Equipment, and ERP / QMS Be able to define, structure and resource a corporate and satellite / plant V&V system(s). Who Will Benefit: Senior management in Drugs, Devices, Biologics, Dietary Supplements QA/RA Professionals, R&D Professionals, Engineering Professionals, Operations Professionals, Manufacturing Professionals, Document Control Professionals For more information, please visit : https://www.complianceglobal.us/product/700458/JohnELincoln/improve-a-master-validation-plan/1 Email: support@complianceglobal.us Toll Free: +1-844-746-4244 Tel: +1-516-900-5515 Level: Intermediate Speaker Profile: John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 33 years' experience in U.S. FDA regulated industries, 19 of which are as an independent consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. He writes a recurring column for the Journal of Validation Technology. John is a graduate of UCLA.

11th Annual Cardiometabolic Health Congress

0
0
The CMHC has over a decade of history bringing together experts across the spectrum of diabetes, obesity, and cardiovascular disease to share ideas and foster collaborations. The program is at the cutting edge of science, translating the latest research to practical approaches for the entire multidisciplinary health care team. CMHC offers live conferences and online educational programs. The target audience for this conference is an interdisciplinary mix of mid to advanced level health care professionals, including primary care clinicians, internists, cardiologists, endocrinologists, obesity specialists, lipidologists, nurse practitioners, physician assistants, pharmacists and Certified Diabetes Educators. For exhibitor/sponsorship opportunities, please contact Kathleen Powell at 561-997-0112 x7507 or kathleen@cardiometabolichealth.org. URL: Booking: https://go.evvnt.com/64375-1 Prices: Allied Health: USD 595 Pysician: USD 695 Fellows/Residents/Students: USD 295 Industry: USD 1195 Speakers: Steven E. Nissen, MD, MACC, Peter Libby, MD, Suzanne Oparil, MD, Ronald C. Kahn, MD, Subodh Verma, MD, PhD, FRCSC Time: 10:00 am - 12:00 pm

Mayo Clinic Opioid:Evidence, Clinical Considerations and Best Practice 2016

0
0
This opioid-focused conference aims to highlight the shift in guidelines and public concern regarding the use of opioids in medical practice. This course provides the most up-to-date information regarding the appropriate indication for opioids in clinical practice. Topics cover the basics of opioids, evidence-based guidelines for opioids, medication monitoring, tapering and legal considerations. In addition, the course covers a broad range of issues, including opioid addiction and difficult patient conversations and guidelines to standardize the practice of opioid prescribing. Medical providers including nurses, nurse practitioners, physician assistants, physicians, addiction experts, pharmacists and others may benefit from this multidisciplinary review and update of opioid management. This course includes lectures by experts in the field of pain medicine and opioid management, panel discussions, and question-and-answer sessions. This continuing medical education course is applicable to nearly all fields within medicine that provide direct patient care. It is germane to all providers who prescribe or administer opioids. Brochure : https://go.evvnt.com/64502-1 Price: MD, DO, PhD, Scientist - USD 625, Resident, Fellow, NP, PA, RN - USD 550 Time : 07:00 - 11:00

Herzmedizin 2017

0
0
46. Jahrestagung der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie und 49. Jahrestagung der Deutschen Gesellschaft für Pädiatrische Kardiologie Schwerpunktthemen DGTHG: - Herz-Kreislaufversagen - Koronare Herzerkrankung - Erworbene Herzklappenerkrankungen - Akute und chronische Erkrankungen der Aorta - Herzrhythmusstörungen - Angeborene Herzfehler im Kindes- und Erwachsenenalter - Intensivmedizinische Herausforderungen - Herz-Kreislauf-Forschung Schwerpunktthemen DGPK: - Elektrophysiologie - Erwachsene mit angeborenem Herzfehler - Fallot'sche Tetralogie - Endokarditis

FDA Chapter 21 CFR Subpart C Section 820.30 – Design Control Requirements - By Compliance Global Inc

0
0
Overview: This webinar will discuss why certain steps are so important in the design process and that many steps are not just wasted time and paperwork. The process is a methodical approach that can be used with almost any product development process from concept to production based on medical device regulations. The speaker has a proven track record of successful products and many of them have been on the market longer than the 5 or 10 year expected product life cycle. The speaker has 20 granted patents and over 83% percent of them have been commercialized and using this process. Why Should You Attend: The medical device design control process can be long and costly, but not if you follow some proven guidelines and steps. Sometimes projects are continuously pushed forward without doing proper reviews to see if the project warrants going to the next step. The sooner this process is done the better as it saves time and money. Good products also need to be completed faster and with less capital to beat the competition to market and beat them with a good quality product that needs little to no revisions and one that receives very few to no complaints from the customer. This webinar will teach you the secrets of turning your medical device ideas into profit making products, which are the same steps that can also enable you to see why the project should be cancelled. Areas Covered in this Webinar: • How to start a new product development process • Patent search for new medical devices • Putting together a comprehensive systems requirement document • 1-10-100 Rule • Market research and customer needs • Design in quality & manufacturability • Prototype & testing • Production Tooling • Qualification, Validation, & Verification • Trace Matrix Learning Objectives: • FDA Chapter 21 CFR Subpart C Section 820.30 – Design Control Requirements • Technical File & Regulatory Documentation for Medical Device Manufacturers • The complete Medical Device Product Development Process Who Will Benefit: • Medical Device Design Engineers • Product Managers • Directors of Product Development • VPs of Product Development • Inventors • Project Leaders • Technical Team Leaders For more information, please visit : https://www.complianceglobal.us/product/700510/KarlRLeinsing/fda-chapter-21-cfr-subpart-c-section-820-30-design-control-requirements/1 Email: support@complianceglobal.us Toll Free: +1-844-746-4244 Tel: +1-516-900-5515 Level: Intermediate Speaker Profile: Karl R. Leinsingis currently the President of ATech Designs, Inc., a Medical Device product development and consulting firm in North Carolina. Karl has Medical Device and automation experience since 1986. His areas of expertise include full life cycle product development of medical devices from conception through development including manufacturing, bench testing, verification, validation, packaging, labeling, clinical trials, regulatory approval, marketing, and sales training. Karl has anM.S. in Mechanical Engineering from North Carolina A&T State University and a Bachelor of Science Degree in Mechanical Engineering from the University of New Hampshire. He is a licensed professional engineer in New Hampshire and has lectured Medical Device and Manufacturing (MD&M) Seminars on The Science of Successful Product Design. He also has a Pilot License for Fixed Wing & Rotorcraft. Karl has been granted 25 patents (others pending), his designs have been published by Life Magazine, was recognized as one of 100 notable people in the medical device industry by the Medical Device & Diagnostic Industry (MD&DI) publication in June 2008, and recently served as chairman of the Medical Device & Manufacturing Conference in 2014. He is the winner of 5 design awards for the SmartSite Valve - 1998 Medical Design Excellence Award (MDEA), 1999 NC Governors New Product Award, 2000 NSPE New Product Award, 2001 Prototype Design Award, and 2003 MDEA Gold Winner.
Viewing all 8759 articles
Browse latest View live




Latest Images